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Edited by Lukas HuberAbstract Studies carried out by immunoﬂuorescence, patch-
clamping and FM dye ﬂuorescence consistently showed that
the Ca2+-induced exocytosis of enlargeosomes, speciﬁc vesicles
expressed by many cell types, is strongly reinforced by pre-treat-
ment of the cells with genistein, a wide spectrum blocker of tyro-
sine kinases, which also induces many additional eﬀects. Various
other blockers of tyrosine kinases, however, were ineﬀective, and
the same occurred with drugs mimicking most of the rapid, non-
tyrosine kinase-dependent eﬀects of genistein. The reinforcement
of enlargeosome-regulated exocytosis, therefore, is a new eﬀect
of genistein and a peculiar property of the enlargeosome exocy-
tosis, not shared by analogous processes.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Immunocytochemistry1. Introduction
Regulated exocytosis, the process by which speciﬁc organ-
elles, both secretory and non-secretory, fuse with the plasma
membrane in response to stimulation, has been investigated
in many cell types. In addition to Ca2+, which in most cells
is the main trigger, other messengers (cAMP, diacylglicerol)
were found to play a stimulatory role. The eﬀects attributed
to tyrosine kinases (TK) were more variable. Reinforcement
of exocytic responses induced by Ca2+ was reported in various
cell systems [1–4]. In others, however, TKs induced no change
[5,6] or inhibited the Ca2+-induced exocytoses [7,8]. Finally, at
brain glutamatergic synapses one laboratory reported a TK-
dependent reinforcement while another reported an inhibition
[9,10].
Many of the above conclusions were not based on direct re-
sults but extrapolated from the eﬀects of TK blockers, most of-
ten the large spectrum isoﬂavone genistein (GNS), used aloneAbbreviations: d/A, desmoyokin/Ahnak; GNS, genistein; NP-EGTA,
o-nitrophenyl EGTA; TK, tyrosine kinase; TRITC, tetramethylrhod-
amine isothiocyanate
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doi:10.1016/j.febslet.2007.09.026or in parallel with other drugs [1,2,4–6,8,9]. This approach,
however, is open to some question. In fact, the various TK
blockers used can have diﬀerent target speciﬁcity; moreover,
their action depends not only on the block of TKs but also
on TK-independent eﬀects, referred to here as additional
eﬀects. The additional eﬀects of GNS are numerous, and some
of them, such as the block of Ca2+ [11,12]; the increase of
cAMP [13,14]; the block of IP3 kinase [15]; the disassembly
of the actin cytoskeleton [16], occur within min from drug
application and therefore can aﬀect exocytosis even in short-
term experiments.
Here we report about reinforcement by GNS of the regu-
lated exocytosis of enlargeosomes. The latter are speciﬁc vesi-
cles, discovered a few years ago in numerous cell types and
abundant in a clone of PC12 cells defective of classical neuro-
secretion, the PC12-27 clone [17–19]. Upon [Ca2+]i increase,
enlargeosomes are rapidly discharged by exocytosis (time con-
stant 1 s [20]), inducing a considerable enlargement of the cell
surface [18–21]. During the characterization of the latter pro-
cess we noticed its strong reinforcement by GNS, occurring
however neither via TK inhibition, nor via the numerous addi-
tional eﬀects of the drug known so far.2. Materials and methods
PC12-27 cells were grown as speciﬁed in [17]. The monoclonal anti-
desmoyokin/Ahnak (d/A) antibody was generated in our laboratory.
tetramethylrhodamine isothiocyanate (TRITC)-conjugated goat anti-
mouse IgGs were bought from Southern Biotech, Birmingham AL,
USA; FM1-43 from Molecular Probes, Eugene, OR, USA; ionomycin,
lavendustinA, herbimycinA, PP2, piceatannol, genistin and forskolin
from Calbiochem, Schwalbach, Germany; GNS, orthovanadate,
daidzein, LY294002, IBMX and H89 from Sigma, Milan Italy;
UO126 from Promega, Madison, WS, USA; latrunculinA from Invit-
rogen, Carlsbad, CA, USA.2.1. Confocal immunoﬂuorescence
For surface immunoﬂuorescence of d/A, PC12-27 cells, grown on
poly-L-lysine-coated coverslips and exposed or not to drug pre-treat-
ment, were challenged or not with ionomycin (3 lM, 3 min) while
bathed at 37 C in Krebs–Ringer–HEPES medium, then transferred
on ice and ﬁxed with 4% formaldehyde in PBS, pH 7.4. After quench-
ing with 0.1 M glycine and washing in PBS containing 0.5% BSA and
5% goat serum (no permeabilization), they were immunolabeled with
the anti-d/A monoclonal and then with the TRITC-labeled secondary
antibody in PBS/BSA. Cells were studied in a Bio-Rad MRC 1024 con-
focal microscope. Quantitation of the data was as in [18].blished by Elsevier B.V. All rights reserved.
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Whole-cell patched PC12-27 cells, loaded with o-nitrophenyl EGTA
(NP-EGTA) with or without GNS (10 lM) in the pipette and recorded
at 37 C in continuous perfusion, were illuminated with a monochro-
matic light (380 nm) short-pass ﬁltered at 410 nm and reﬂected in the
perfusion chamber by a dichroic mirror centered at 400 nm, suﬃcient
to release the caged Ca2+ continuously [18]. Compensated membrane
capacitance (Cm), access conductance (Ga), membrane current and
membrane potential were recorded unﬁltered and then analyzed as in
[18]. Values given as % DC/Cslow correspond to the % increases of
the cell surface area.2.3. FM styryl dye ﬂuorescence
PC12-27 cell suspensions in KRH were transferred to ﬂuorometer
cuvettes and kept under continuous stirring. FM1-43 dye was added
to 4 lM (ﬁnal concentration). After 5 min, necessary to reach the
dye equilibration, the cells were pretreated or not with the drugs and
then exposed to ionomycin, and ﬂuorescence intensity changes were
recorded on-line (excitation and emission wavelengths: 479 and
598 nm) using a LS50B ﬂuorometer (Perkin–Elmer, Wellesley, MA,
USA) [19].2.4. Statistics
Data were analyzed by the Student’s t-test.3. Results and discussion
Enlargeosomes are non-secretory organelles [17,22]. Their
regulated exocytosis, therefore, can be investigated by moni-
toring not the discharge of a product, but the appearance to
the cell surface of their luminal protein marker, d/A [17–
19,21]. PC12-27 cells, untreated (Fig. 1A, E) and pretreated
for 5 min with GNS (10, 30, 60 [not shown] and 100 lM
(Fig. 1B, E)) were almost d/A-negative. Three minutes treat-
ment with 3 lM ionomycin, a Ca2+ ionophore, induced a con-
siderable increase of the surface d/A labelling (Fig. 1C, E)
which was much reinforced in the cells pretreated with GNS
(Fig. 1D, E).
The diﬀerence between ionomycin and GNS + ionomycin-
induced responses could be due to increased exocytosis, de-
creased endocytosis/shedding, or both. To distinguish between
these possibilities we monitored by whole-cell patch-clamping
the changes of capacitance, i.e. of cell surface area, taking
place during caged Ca2+ photolysis [18], a process that induces
[Ca2+]i increases to lM levels without involvement of surface
and intracellular channels [18]. Fig. 2A–C shows that, in cells
pretreated with 10 lMGNS, the rise of capacitance induced by
caged Ca2+ photolysis was twice as fast and 2.5 larger than in
non-pretreated cells. These results exclude a major contribu-
tion of enlargeosome endocytosis, which takes place in min
[18,19], and demonstrate the GNS-induced reinforcement of
the Ca2+-induced exocytosis.
Increases of cell surface area can be assayed also by ﬂuorom-
etry, using styryl FM dyes [19]. Fig. 2D, E shows FM1-43 re-
sults very similar to those obtained by patch-clamping,
conﬁrming, by using ionomycin, the large reinforcement of
the [Ca2+]i-induced exocytosis in cells pretreated with GNS;
Fig. 2F, that the reinforcement occurred at GNS concentra-
tions (10–300 lM) known to inhibit TKs; Fig. 2G, that the
drug did not shift the dose-dependence of the ionomycin-in-
duced cell surface enlargement rate but increased the eﬃcacy
of the ionophore; Fig. 2H, that the GNS reinforcement ap-peared after a few minutes and faded out after longer pre-treat-
ments, suggesting a progressive desensitization.
Many drugs acting on either TKs or other GNS targets were
employed to investigate the mechanism of the reinforcement.
Table 1 illustrates the action, low or absent, of various TK
blockers and of drugs aﬀecting additional, non-TK-dependent
eﬀects of GNS: lavendustinA, a large-spectrum blocker of TKs
known to induce only few additional eﬀects; the Src inhibitors,
herbimycinA and PP2; piceatannol, a blocker of Syk and Lck;
orthovanadate, an inhibitor of the tyrosine phosphatases,
administered alone or together with GNS; daidzein, which in-
duces most of the non-TK eﬀects of GNS; UO126, a blocker of
MEKs; LY294002, an inhibitor of PI3 kinase; forskolin and
IBMX, which increase [cAMP]i by stimulation of adenylate cy-
clase and inhibition of phosphodiesterase, respectively; H89, a
blocker of protein kinase A. Also genistin, an inactive GNS
analogue, failed to show any reinforcing eﬀect.
The eﬀect of GNS on the [Ca2+]i response to ionomycin
could not be checked directly because the ﬂorescence of the
isoﬂavone interferes with that of [Ca2+]i dyes. A role of
[Ca2+]i in the GNS reinforcement, however, appears highly
unlikely because (1) in PC12-27 cells the exocytic response
to 3 lM ionomycin is poorly aﬀected by agents, such as bra-
dikynin, that induce [Ca2+]i rises by independent mechanisms;
and (2) the GNS reinforcement was unchanged in cells pre-
loaded with the cytosolic Ca2+ chelator BAPTA (30 min incu-
bation with 30 lM BAPTA-AM) (not shown). To investigate
the involvement of the actin cytoskeleton we compared the
reinforcement by GNS to that by latrunculinA, an actin
depolymerizing drug also known as a stimulator of enlargeo-
some exocytosis [21]. The reinforcement by latrunculinA
(5 lM, 15 min) was smaller than that by GNS (Fig. 3). Inter-
estingly, when the two drugs were combined, reinforcement
was not additive. Overall, the results of Table 1 exclude the
involvement of TK inhibition and of known additional eﬀects
of GNS. In contrast, an alteration of the cytoskeleton
might contribute to the reinforcement of enlargeosome exocy-
tosis.
Until recently, regulated exocytosis was identiﬁed with the
ﬁnal event of regulated secretion. Since 15 years, however,
many non-secretory regulated exocytoses have been identiﬁed,
necessary for important functions taking place either ubiqui-
tously or in specialized cell types [22]. Enlargeosomes are
widely expressed, non-secretory exocytic vesicles involved in
the cell surface traﬃcking of membranes. Various properties
of enlargeosomes and of their exocytosis: neutral pH of the
lumen, membrane speciﬁcity, kinetics of discharge, recycling
of the exocytized membrane [19–22], are distinct from those
of other exocytic organelles. The reinforcement by GNS of
the Ca2+-induced exocytosis of enlargeosomes appears
remarkable in size, analogous to eﬀects of the drug observed
previously only in neurons and pancreatic b cells. The latter ef-
fects, however, are induced by Src-speciﬁc blockers [8,9] that in
our system were inactive. Our data revealed therefore a new
property of enlargeosomes, distinct from those of the other
exocytic organelles; and a new additional eﬀect of GNS, inde-
pendent on both the TK block and the non-TK eﬀects of the
drug known so far. Although poorly deﬁned in mechanistic
terms, our results may contribute to a comprehensive knowl-
edge of the pharmacology of an important drug, widely em-
ployed in signal transduction studies.
Fig. 2. Cell surface increases induced by ionomycin in cells pretreated or not with GNS, revealed by patch-clamping and FM1-43. Panel A shows
typical capacitance patch clamp traces of PC12-27 cells stimulated by uncaging NP-EGTA (arrow) after no pre-treatment (control) or pre-treatment
with GNS; panels B and C the analyzed patch-clamp data (7–8 cells/group) showing the rate of the capacitance increase (B) and the extent of the
responses (C). Panels D and E show the FM1-43 responses analogous to the patch-clamp responses of A and B, where pre-treatment was with GNS
100 lM, 5 min, and the exocytosis was triggered by the administration of ionomycin 3 lM (13 experiments). Panels F and G show the concentration-
dependence of the responses induced by one of the two drugs in the presence of a ﬁxed concentration of the other: GNS at various concentrations
followed by ionomycin 3 lM; and ionomycin at various concentrations preceded by GNS 100 lM (three experiments). Panel H shows the
reinforcement induced by GNS (100 lM) pre-treatment of 5, 15 and 30 min. In all panels control = ionomycin alone, 3 lM (21 experiments).
Diﬀerences with respect to controls in panels B, C, and E–H are all statistically signiﬁcant (P < 0.05 or lower) except for the 0.1 lM ionomycin and
the 30 min value of panels G and H.
Fig. 1. Surface immunoﬂuorescence of the enlargeosome marker, d/A, indicative of recent exocytosis. Panels A and B show that resting PC12-27
cells, pretreated (B) or not (A) with GNS (5 min, 100 lM) exhibit very low immunoﬂuorescence, which in contrast is increased in the cells stimulated
with ionomycin (3 lM, 3 min) (panel C), especially when pretreated with GNS (D). The bar in A, valid also for the other panels, is 5 lm. Data in E
were from at least 20 randomly selected cell/groups. Diﬀerences of ionomycin and GNS + ionomycin versus control, and ionomycin versus
GNS + ionomycin are highly signiﬁcant (P < 0.01).
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Table 1
Enlargeosome exocytosis: lack of reinforcement of the ionomycin-induced response by drugs other than GNS, aﬀecting tyrosine phosphorylation
and/or inducing additional (non-TK-dependent) eﬀects of GNS
Drug
targets
Concentrations
used (lM)
Preincubation
(min)
Rate of Fluo
Change (a.u.)/sec
Fold changes
versus ionomycin
GNS TKs and non-TKs 100a 5 3.5 ± 0.46 2.5
LavendustinA TKs 10a 5 1.33 ± 0.3 0.3
HerbimycinA Src family TKs 1 15 1.15 ± 0.17 0.15
PP2 Src TKs 10 15 1.3 ± 0.7 0.3
Piceatannol Syk, Lck TKs 10 15 0.75 ± 0.05 0.25
Orthovanadate Tyrosine phosphatases 10a 15 0.63 ± 0.07 0.37
GNS + orthovanadate TKs and non-TKs + tyrosine phosphatases 100 + 10 5 + 15 3.25 ± 0.25 2.25
Daidzein Non-TKs 100a 5 0.9 ± 0.15 0.1
UO126 MEK1, MEK2 10a 60 0.95 ± 0.15 0.05
LY294002 PI3 kinase 25 30 1.1 ± 0.1 0.1
Forskolin Adenylate cyclase 1a 10 1.5 ± 0.5 0.5
IBMX Phosphodiesterase 500 5 0.95 ± 0.05 0.05
H89 Protein kinase A 10 30 0.89 ± 0.1 0.11
Genistin Inactive GNS analogue 100 5 0.75 ± 0.05 0.25
Results shown are averages of at least three experiments carried out by FM1-43 ﬂuorometry of cell suspensions.
aIndicates drugs used also at other concentrations (lM), with consistent results: GNS: 10, 30, 60, 300; lavendustinA: 10, 100; orthovanadate: 10, 100;
daidzein: 100, 300; UO126: 1, 10; forskolin: 1, 10. Except for GNS (P < 0.01), the diﬀerences in rate of ﬂuorescence change with respect to controls
(ionomycin alone) were non-signiﬁcant (P > 0.05).
Fig. 3. Reinforcement of the ionomycin-induced exocytosis by pre-
treatment with GNS or/and latrunculinA. Pre-treatment with latr-
unculinA (5 lM) was for 15 min; that with GNS (100 lM) for 5 min.
In the combined treatment the cells received the ﬁrst at 15 and the
second at 5 min. Control = ionomycin alone, 3 lM. Results from
three experiments. Diﬀerences with respect to control (P < 0.01) and
GNS versus latrunculinA (P < 0.05) are signiﬁcant; GNS + latruncu-
linA versus GNS is not (P > 0.05).
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